Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.
Follow PHG
Koninklijke Philips N.V. (PHG) P/E ratio
As of 16 October 2026, Koninklijke Philips N.V. (PHG) trades at a P/E ratio of 18.8×. Over the past ten years it has ranged from 0.0× (September 2024) to 59.0× (April 2015); the current reading is higher than 39% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 24.9× | (8.66%) |
| FY2024 | 27.2× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 4.7× | (82.97%) |
| FY2020 | 27.6× | 50.32% |
| FY2019 | 18.3× | 37.94% |
| FY2018 | 13.3× | (28.23%) |
| FY2017 | 18.5× | 6.24% |
| FY2016 | 17.4× | (45.87%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 19.9× | (13.09%) |
| Mar 2026 | 22.9× | (8.10%) |
| Dec 2025 | 24.9× | (26.11%) |
| Sep 2025 | 33.7× | 55.78% |
| 36 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 16.0× |
| PHG Koninklijke Philips N.V. | 18.8× |
| GMED Globus Medical, Inc. compare | 19.3× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 23.0× |
| STE STERIS plc compare | 27.1× |
| DXCM DexCom, Inc. compare | 33.2× |
| SNN Smith & Nephew SNATS, Inc. compare | 35.4× |
| EW Edwards Lifesciences Corporation compare | 49.8× |
| PEN Penumbra, Inc. compare | 78.4× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)